Sign up to save your podcasts
Or
Share CNS Summit Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CNS Summit Podcast
CNS Summit Podcast episodes
- S2: E05: Dr. Amy Abernethy on the Role of Technology Within the Biomedical Landscape
Hear how Dr. Amy Abernethy, Principle Deputy Commissioner and current Acting CIO of the FDA sees the role of technology, including AI and RWE in the drug development landscape.
Fireside chat featuring:
- Dr. Amy Abernethy, the Principle Deputy Commissioner and current Acting CIO of the FDA
- Dr Amir Kalali, Chief Curator of CNS Summit
Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter (@cnssummit).
Hear and subscribe to all the episodes in this series on Health Podcast Network.
28 min - S2: E04: Ali Parsa of Babylon Health on Affordable and Accessible Healthcare
Hear how Ali Parsa, CEO of Babylon Health sees the future of enabling accessible and affordable health service to every person on earth using quantum computing, 5G networks, IoT, prescriptive analytics, augmented reality and robotics. This episode was recorded on the main stage at the 2019 CNS Summit in Boca Raton, Florida.
Panel discussion featuring:
- Ali Parsa, CEO of Babylon Health
- Dr Amir Kalali, Chief Curator of CNS Summit
- Dr Junaid Bajwa, Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck
Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter (@cnssummit).
Hear and subscribe to all the episodes in this series on Health Podcast Network.
12 min - S2: E03: Jessica Mega of Verily on Life Sciences and Technology
Hear how Jessica Mega, Chief Medical and Scientific Officer at Verily, sees the intersection of life science, healthcare and technology through research programs, such as Project Baseline.
Panel Conversation featuring:
- Jessica Mega, Chief Medical and Scientific Officer at Verily
- Dr. Reed Tuckson, Managing Director of Tuckson Health Connections
- Dr Amir Kalali, Chief Curator of CNS Summit
Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter (@cnssummit).
Hear and subscribe to all the episodes in this series on Health Podcast Network.
27 min - S2: E02: MIT Professor, Dina Katabi on Wearables to Invisibles
Hear how MIT Professor Dina Katabi sees the future of neurodegenerative diseases like Parkinson's and Huntington's, mood disorders and GI and Immune system diseases with applications like wearables and AI.
Fireside Chat Featuring:
- Dina Katabi, Andrew & Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT
- Dr Amir Kalali, Chief Curator of CNS Summit
This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter @cnssummit.
Hear and subscribe to all the episodes in this series on Health Podcast Network.
18 min - S2: E01: Innovations in Psychedelics for Mental Healthcare with George Goldsmith and Ekaterina Malievskaia
Hear how George Goldsmith and Ekaterina Malievskaia from COMPASS Pathways are working to bring innovation psychedelic drug applications for depression. Learn what what this means for patients, regulators and trials.
Panel Conversation Featuring:
- George Goldsmith Co-Founder and Executive Chairman of COMPASS Pathways
- Dr Ekaterina Malievskaia, Research and Development at COMPASS
- Jane Metcalf, Founder of Neo.Life
- Dr Amir Kalali, Chief Curator of CNS Summit
This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter (@cnssummit).
Hear and subscribe to all the episodes in this series on Health Podcast Network.
32 min - Bonus: CNS Summit Call on the Impact of COVID-19 Crisis on Clinical Trials
This is a special episode of a webinar that was recorded on Friday, May 8, 2020.
In this recording, we hear from Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO of the FDA, as she speaks with Dr Amir Kalali, Chief Curator of CNS Summit.
Drs. Abernethy and Kalali discuss:
- How Covid-19 is impacting drug development
- How the FDA is aligning and responding to the pandemic
- Unexpected ways the pandemic may influence clinical research and medicine
For more podcasts like this, be sure to subscribe to the CNS Summit Podcast on Apple Podcasts, Google Podcasts or Spotify, and you can also find us on Health Podcast Network at HealthPodcastNetwork.com
Learn more about the CNS Summit and follow us on Twitter (@cnssummit) to find out more about upcoming events, news and announcements.
53 min - S1: E4: Myrtle Potter of Roivant Sciences on the near future of drug development innovationMyrtle Potter is one of America’s foremost healthcare leaders and innovators. She is Vant Operating Chair at Roivant Sciences, a global biopharmaceutical company that currently has thirty investigational drugs in eleven therapeutic areas being tested in over fifty clinical trials across the Roivant family of companies. She is also founder of Myrtle Potter & Company, LLC, a healthcare and life science advisory firm that has operated since 2005.Myrtle was president and chief operating officer of Genentech, Inc. where, from 2000 to 2005, she led the company through one of the most successful periods in its history. Genentech achieved record sales and earnings growth during each of the five years she led the company and sales grew more than five-fold to over $5 billion over the same period. Under her leadership the company launched seven breakthrough products including Avastin™, the blockbuster cancer treatment. During her tenure she served on the Executive Committee of the Company and co-chaired the Product Portfolio Committee which made all investment and “go/no go” decisions for Genentech’s drug pipeline.Myrtle is also an independent director of Rite Aid Corporation, Liberty Mutual Holding Company, Proteus Digital Health, Insmed and Axsome. She also serves on the University of Chicago Board of Trustees. Formerly she served on the boards of Amazon, FoxHollow Technologies, eV3, Medco Health Solutions and Express ScriptsMyrtle was named to FORTUNE Magazine’s list of Most Powerful Women in Business on three separate occasions. Her business and leadership has been recognized by BusinessWeek, The Wall Street Journal, FORTUNE Magazine, TIME Magazine, Forbes, Black Enterprise Magazine, Savoy and Harvard Business Review. Myrtle earned a B.A. from The University of Chicago.Learn more about the CNS Summit and follow us on Twitter (@cnssummit).Listen to this episode on Health Podcast Network.15 min
- S1: E3: Eric Perkaslis on research, informatics, technology
Eric is currently Chief Science Officer at Datavant and Visiting Scientist at the Department of Biomedical Informatics at Harvard Medical School.
Most recently, Eric was Senior Vice President Data Sciences at Takeda R&D. Previously, Eric was the Executive Director of the Center for Biomedical Informatics and the Countway Library of Medicine at Harvard Medical School. Eric served as the CIO and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. Eric has also served as Senior Bioinformatics Advisor at Precision for Medicine, as the Chair of the ASCO CancerLinQ technology advisory and on the Editorial Board of the DIA flagship journal, Journal of Regulatory Science and Innnovation
Prior to FDA, Eric was Senior Vice President of R&D IT at J&J Pharmaceuticals R&D. Eric also held the posts of Vice President R&D Informatics, Vice President and CIO, Director of Research IT, Assistant Director and Director of Drug Discovery Research at J&J.
Eric has a PhD in chemical and biochemical engineering from Drexel University.
Learn more about the CNS Summit and follow us on Twitter (@cnssummit).
Listen to this episode on Health Podcast Network.
11 min - S1: E2: A conversation with Deborah Dunsire, CEO and President of Lundbeck
Deborah Dunsire is the CEO and President of Lundbeck. Prior to that, she was the CEO and President of FORUM Pharmaceuticals and the CEO and President at Millennium Pharmaceuticals. She has more than 25 years of scientific, clinical, operational and commercial experience, and proven leadership in the biological and pharmaceutical industry. Dr. Dunsire holds a Doctor of Medicine from the University of Witwatersand, Johannesburg, South Africa.
Learn more about the CNS Summit and follow us on Twitter (@cnssummit).
Listen to this episode on Health Podcast Network.
29 min - S1: E1: Insights from Vivek Ramaswamy, founder and CEO, Roivant Sciences
Vivek Ramaswamy is the founder and CEO of Roivant Sciences, the parent of a growing family of companies focused on diverse areas including women’s health, rare diseases, neurology, cardiometabolic diseases, urology, dermatology, RNA therapeutics, and healthcare data.
Learn more about the CNS Summit and follow us on Twitter (@cnssummit).
Listen to this episode on Health Podcast Network.
31 min
About CNS Summit Podcast
From the publisher's feed
CNS Summit is a platform for change and a community passionate about shaping the future with a focus on collaboration, innovation and technology. Our mission is to have a positive impact on the…
success of clinical development programs. We believe this mission is our ethical duty to the patients we serve by developing new treatments. If this mission resonates with you, and you would like to be surrounded by creative, passionate, and future-focused colleagues join us!